Biogened Dividend
Dividend criteriumcontroles 2/6
Biogened is a dividend paying company with a current yield of 2.14% that is well covered by earnings. Next payment date is on 18th November, 2024 with an ex-dividend date of 12th September, 2024.
Belangrijke informatie
2.1%
Dividendrendement
n/a
Terugkoop Rendement
Totaal aandeelhoudersrendement | n/a |
Toekomstig dividendrendement | n/a |
Dividendgroei | n/a |
Volgende betaaldatum dividend | 18 Nov 24 |
Ex-dividenddatum | 12 Sep 24 |
Dividend per aandeel | zł0.500 |
Uitbetalingsratio | 23% |
Recente dividendupdates
Recent updates
A Piece Of The Puzzle Missing From Biogened S.A.'s (WSE:BGD) 25% Share Price Climb
Aug 28Impressive Earnings May Not Tell The Whole Story For Biogened (WSE:BGD)
Aug 22Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding
May 23Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden
May 09Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations
Feb 21Is Biogened (WSE:BGD) A Risky Investment?
Feb 01Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump
Feb 01We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt
Jun 30Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly
Oct 08Is Biogened (WSE:BGD) A Risky Investment?
Jun 29Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?
Mar 25These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well
Dec 09Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet
Jul 29Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly
Apr 30Is Biogened (WSE:BGD) A Risky Investment?
Jan 24Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: Whilst dividend payments have been stable, BGD has been paying a dividend for less than 10 years.
Groeiend dividend: BGD's dividend payments have increased, but the company has only paid a dividend for 3 years.
Dividendrendement versus markt
Biogened Dividendrendement versus markt |
---|
Segment | Dividendrendement |
---|---|
Bedrijf (BGD) | 2.1% |
Markt onderkant 25% (PL) | 2.8% |
Markt Top 25% (PL) | 8.0% |
Gemiddelde industrie (Pharmaceuticals) | 2.4% |
Analist prognose (BGD) (tot 3 jaar) | n/a |
Opmerkelijk dividend: BGD's dividend (2.14%) isn’t notable compared to the bottom 25% of dividend payers in the Polish market (2.82%).
Hoog dividend: BGD's dividend (2.14%) is low compared to the top 25% of dividend payers in the Polish market (7.96%).
Winstuitkering aan aandeelhouders
Verdiendekking: With its low payout ratio (22.9%), BGD's dividend payments are well covered by earnings.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: With its reasonably low cash payout ratio (30.1%), BGD's dividend payments are well covered by cash flows.